je.st
news
No Rehearing Of Biosimilar Patent Dance Decision
2015-10-21 00:14:28| Biotech - Topix.net
The Federal Circuit denied the petitions for rehearing en banc filed in Amgen Inc. v. Sandoz Inc. , which was the court's first decision interpreting the Biologics Price Competition and Innovation Act .
Tags: decision
dance
patent
rehearing
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||